Marc Wilson Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months, 3 weeks ago
Marc Wilson has an estimated net worth of at least $10.7 million*, as of Jan. 8, 2025. They own 111,092 shares of CRNX stock. They have sold 126,920 shares of CRNX stock since 2021, for an estimated $5.2 million.
Marc Wilson $CRNX SEC Form 4 Insider Trading
Marc Wilson has filed a total of 8 insider trades in $CRNX since 2021. Their most recent trade was a sale of 25,000 shares, made on Sep 26, 2024. Their largest trade was a sale of 25,000 shares, made on Sep 26, 2024. We estimate that they now own 111,092 shares of $CRNX, worth an estimated $5.5 million.
Insider Trading at $CRNX
There have been a total of 116 insider trades reported at $CRNX since 2021, with 1.4 million shares purchased and 1.3 million shares sold. The most active insider traders in $CRNX stock have been Stephen F. Betz, Richard Scott Struthers, and Dana Pizzuti. The most recent trade was a sale of 2,388 shares reported by Dana Pizzuti (Chief Med and Dev Officer), made on Mar 19, 2025.
History of Insider Stock Trades by Marc Wilson
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CRNX
|
Sale | 25,000 | Sep 26, 2024 | Sept. 30, 2024, 5:01 p.m. |
|
CRNX
|
Sale | 19,056 | Jul 25, 2024 | July 26, 2024, 4:24 p.m. |
|
CRNX
|
Sale | 25,000 | Jul 15, 2024 | July 17, 2024, 5:14 p.m. |
|
CRNX
|
Sale | 6,942 | Mar 19, 2024 | March 20, 2024, 6:32 p.m. |
|
CRNX
|
Sale | 10,000 | Jan 02, 2024 | Jan. 4, 2024, 5:43 p.m. |
|
CRNX
|
Sale | 10,000 | Nov 01, 2023 | Nov. 3, 2023, 7:38 p.m. |
|
CRNX
|
Sale | 10,922 | Jun 20, 2023 | June 21, 2023, 5:32 p.m. |
|
CRNX
|
Sale | 20,000 | Jun 20, 2023 | June 21, 2023, 5:32 p.m. |
$CRNX Executives and Stock Owners with Insider Trades
-
Stephen F. Betz, Chief Scientific Officer
-
Richard Scott Struthers, President & CEO
-
Dana Pizzuti, Chief Med and Dev Officer
-
Jeff E. Knight, Chief Operating Officer
-
Marc Wilson, CFO
-
Ajay Madan, Chief Development Officer
-
Alan Seth Krasner, Chief Medical Officer
-
James Hassard, Chief Commercial Officer
-
Dana Pizzuti, Chief Development Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.